share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

SEC announcement ·  Jun 5 03:03
Summary by Futu AI
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.